Teletherapy trial tests whether remote speech-language care can narrow language gaps in deaf toddlers
Children who are deaf or hard-of-hearing face a well-described risk of speech and language delay, and the gap widens when family income limits access to specialized therapy. This multicenter protocol is built around a simple clinical question with major equity implications: can speech-language teletherapy improve language outcomes for low-income children who are deaf or hard-of-hearing, and can it do so in a way that is practical for real-world care delivery?
The study was designed as an inclusive comparative effectiveness trial after stakeholder input and pilot data collection. Rather than treating access barriers as a peripheral issue, the protocol places them at the center of the intervention. That approach matters in pediatric hearing care, where therapy intensity, family logistics, transportation, and appointment availability can all shape whether a child receives enough language support during the most sensitive window for early development.
A randomized design paired with a comparison cohort
Investigators plan to conduct the trial at four tertiary children’s hospitals in the United States. The full study population will include 210 children who are deaf or hard-of-hearing, all between 0 and 27 months of age. Of those, 140 children from lower income households will be randomized 1:1 to receive usual care alone or usual care plus access to supplemental speech-language teletherapy. A separate cohort of 70 children from higher income households will be recruited in parallel as a comparison group.
This structure does more than test a service delivery model. It allows the investigators to examine whether adding teletherapy to usual care changes language trajectory in the group most likely to face structural barriers, while also anchoring those results against a higher-income comparator cohort. In early childhood hearing care, where baseline exposure to spoken language and access to therapy may differ sharply by household resources, that parallel design offers a direct window into disparity reduction rather than simple treatment efficacy.
The trial’s primary outcome is the Preschool Language Scales Auditory Comprehension subscale standard score. Secondary outcomes will extend across speech, language, hearing, and quality-of-life measures, using validated instruments. That choice is clinically important because receptive language often tracks closely with downstream communication development, school readiness, and caregiver confidence. Measuring only one domain would miss the broader effect that early intervention can have on family functioning and developmental progress.
Why teletherapy is being tested in this age group
The biological and developmental logic behind the protocol is straightforward. Early language acquisition depends on consistent, repeated exposure to accessible language input. For children with hearing loss, the pathway to that exposure is often interrupted by delayed referral, limited specialist availability, or the practical burden of frequent in-person visits. Teletherapy can reduce those barriers by bringing specialized speech-language care into the home, where participation may be easier to sustain during infancy and toddlerhood.
The protocol is also an attempt to move beyond the usual pattern in pediatric trials, where families from lower socioeconomic backgrounds are underrepresented despite carrying a disproportionate burden of adverse outcomes. Inclusive enrollment is not a cosmetic feature here; it is the core of the study question. Without diverse participation, any intervention aimed at closing language gaps risks being tested only in families already able to navigate specialty care.
Equity was built into the trial design before enrollment began
Stakeholder input shaped decisions about comparator groups, masking, assessments, and compensation. That kind of planning can determine whether a trial is feasible for families whose circumstances differ from those typically represented in research settings. In pediatric hearing health, inclusive design may influence retention as much as recruitment, especially when families juggle work schedules, travel burdens, and repeated therapy appointments for a child younger than 3 years.
The protocol also reflects a broader shift in hearing-health research toward intervention models that can be integrated into routine care. A teletherapy platform may be easier to scale than repeated in-person specialty visits, particularly in regions where pediatric speech-language pathology resources are limited. If the intervention improves access and outcomes in the lower-income cohort, it could create a practical model for reducing the early language gap that often persists into later childhood.
What the protocol can and cannot answer yet
Because this is a study protocol, no efficacy results are available yet. The value of the report lies in the trial architecture, the targeted population, and the intention to measure outcomes that matter clinically rather than relying on proxy endpoints alone. The study will be judged by whether teletherapy improves auditory comprehension and related developmental measures enough to justify broader implementation in routine pediatric hearing care.
The inclusion of a higher-income comparison cohort is particularly relevant. It may help clarify whether differences in language outcome are driven by income-linked access barriers, by the intervention itself, or by a combination of both. In a field where social determinants shape treatment opportunity as strongly as audiologic severity, the ability to compare trajectories across income strata is likely to be as informative as the randomized comparison.
One sentence captures the central challenge: access alone does not guarantee language gains. The intervention must be feasible, usable, and effective enough to change developmental outcomes during the short period when language circuits are most responsive.
Ethical oversight and planned dissemination
The trial received approval from the Institutional Review Boards at the participating sites: the University of California, San Francisco; Rady Children’s Hospital; and Seattle Children’s Hospital. Parents of enrolled children will provide written informed consent. The protocol also plans structured dissemination through publication and through national and regional organizations, with professional and parent stakeholder groups involved throughout the design process helping move results into practice if the findings support implementation.
Clinical trial registration is listed under NCT04928209. The next question is not whether teletherapy is convenient, but whether it can deliver measurable language benefit for children whose families have had the least access to specialized care. If the trial succeeds, it could define a more equitable model for early speech-language intervention in deaf and hard-of-hearing children; if it falls short, the field will still gain a rigorously designed framework for testing access-focused hearing interventions in the youngest patients.